SUN-259 Recombinant Growth Hormone Therapy for Children with Turner Syndrome in Korea: A Phase III Randomized Trial

Background: Short stature is the most consistent characteristic feature of Turner syndrome (TS). Several studies have been performed to evaluate growth response to growth hormone (GH) for children with TS and shown that earlier and proper treatment with GH improves growth. Objectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jinsup, Suh, Byung-Kyu, Ko, Cheol Woo, Lee, Kee-Hyoung, Yoo, Han-Wook, Shin, Choong Ho, Hwang, Jin Soon, Kim, Ho-Seong, Chung, Woo-Yeong, Kim, Chan Jong, Han, Heon-Seok, Jin, Dong Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553382/
http://dx.doi.org/10.1210/js.2019-SUN-259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553382/
http://dx.doi.org/10.1210/js.2019-SUN-259

Ejemplares similares